RIGL - リジェル・ファ―マシュ―ティカルズ (Rigel Pharmaceuticals Inc.)

RIGLのニュース

   Rigel Pharmaceuticals : Corporate Presentation August 2020 | MarketScreener  2020/08/19 14:12:07 MarketScreener
quick to patients, if approved Significant Opportunity Providing support for ongoing … | August 19, 2020
   Why Rigel Pharmaceuticals Is Moving Today  2020/07/27 20:04:12 Benzinga
Rigel Pharmaceuticals (NASDAQ: RIGL ) shares are trading higher on Monday after the company announced the publication of post-hoc data analysis of TAVALISSE in the British Journal of Haematology. Rigel Pharmaceuticals develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead … Full story available on Benzinga.com
   Thinking about buying stock in Moleculin Biotech, VBI Vaccines, Rigel Pharmaceuticals, Delta Air Lines, or Vivint Solar?  2020/07/15 13:31:00 PR Newswire
NEW YORK, July 15, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MBRX, VBIV, RIGL, DAL, and VSLR. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Rigel rallies on launch of fostamatinib study in COVID-19 (NASDAQ:RIGL)  2020/07/14 12:01:35 Seeking Alpha
Rigel Pharmaceuticals (NASDAQ:RIGL) announces that the Imperial College London has launched a study to assess fostamatinib in patients with COVID-19 pneumo
   Rigel's stock jumps 25% after announcing U.K. trial for possible COVID-19 treatment  2020/07/14 11:49:34 MarketWatch
Shares of Rigel Pharmaceuticals Inc. undefined gained 25% in premarket trading on Tuesday after announcing that a drug used to treat an autoimmune disorder…
   Why Rigel Pharmaceuticals Is Moving Today  2020/07/27 20:04:12 Benzinga
Rigel Pharmaceuticals (NASDAQ: RIGL ) shares are trading higher on Monday after the company announced the publication of post-hoc data analysis of TAVALISSE in the British Journal of Haematology. Rigel Pharmaceuticals develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead … Full story available on Benzinga.com
   Thinking about buying stock in Moleculin Biotech, VBI Vaccines, Rigel Pharmaceuticals, Delta Air Lines, or Vivint Solar?  2020/07/15 13:31:00 PR Newswire
NEW YORK, July 15, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MBRX, VBIV, RIGL, DAL, and VSLR. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Rigel rallies on launch of fostamatinib study in COVID-19 (NASDAQ:RIGL)  2020/07/14 12:01:35 Seeking Alpha
Rigel Pharmaceuticals (NASDAQ:RIGL) announces that the Imperial College London has launched a study to assess fostamatinib in patients with COVID-19 pneumo
   Rigel's stock jumps 25% after announcing U.K. trial for possible COVID-19 treatment  2020/07/14 11:49:34 MarketWatch
Shares of Rigel Pharmaceuticals Inc. undefined gained 25% in premarket trading on Tuesday after announcing that a drug used to treat an autoimmune disorder…
   Rigel Pharmaceuticals (RIGL) Q1 Earnings Match Estimates  2020/05/05 22:15:09 Zacks Investment Research
Rigel (RIGL) delivered earnings and revenue surprises of 0.00% and -2.08%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   Thinking about buying stock in Moleculin Biotech, VBI Vaccines, Rigel Pharmaceuticals, Delta Air Lines, or Vivint Solar?  2020/07/15 13:31:00 PR Newswire
NEW YORK, July 15, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MBRX, VBIV, RIGL, DAL, and VSLR. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Rigel rallies on launch of fostamatinib study in COVID-19 (NASDAQ:RIGL)  2020/07/14 12:01:35 Seeking Alpha
Rigel Pharmaceuticals (NASDAQ:RIGL) announces that the Imperial College London has launched a study to assess fostamatinib in patients with COVID-19 pneumo
   Rigel's stock jumps 25% after announcing U.K. trial for possible COVID-19 treatment  2020/07/14 11:49:34 MarketWatch
Shares of Rigel Pharmaceuticals Inc. undefined gained 25% in premarket trading on Tuesday after announcing that a drug used to treat an autoimmune disorder…
   Rigel Pharmaceuticals (RIGL) Q1 Earnings Match Estimates  2020/05/05 22:15:09 Zacks Investment Research
Rigel (RIGL) delivered earnings and revenue surprises of 0.00% and -2.08%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release  2020/04/28 16:33:42 Zacks Investment Research
Rigel (RIGL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

calendar